|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1800 M Street, NW |
Address2 | Suite 740S |
| City | Washington |
State | DC |
Zip Code | 20036 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 43536-12
|
||||||||
|
6. House ID# 322500000
|
||||||||
| TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Seth A. Chase |
Date | 1/19/2018 4:55:22 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Statement supporting increasing the FY 2018 appropriations for CDC and HRSA.
Letter to House and Senate leadership to support raising the non-defense discretionary spending cap and support $552 million for the Health Resources and Services Administration (HRSA)s Title VII health professions and Title VIII nursing education programs.
Meeting with Senate HELP staff to discuss Sen. Murrays priorities for the HELP Committee and the Senate, Labor, HHS, Education Appropriations subcommittee.
A statement to encourage the Senate to fund the Title VIII Nursing Workforce Development Programs at $234.472 million and the National Institutes of Nursing Research at $155.210 million.
A letter to the chair and ranking member of the Senate Labor, HHS, Ed. Appropriations subcommittee supporting increasing the FY 2018 appropriations for CDC and HRSA.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Seth |
Chase |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Letter to senators who sponsored a Graham/Cassidy proposal that would repeal and amend provisions of the Patient Protection and Affordable Care Act to share concerns that their proposed changes would result in reductions in health care coverage, particularly for individuals with substance use disorders and mental illness.
Letter to sponsors supporting HR 3255/S 2122 the Supporting Working Moms Act.
Letter to sponsors supporting HR 2375/S 1110 the Friendly Airports for Mothers Act.
Letter to senators urging them to vote no on the Graham-Cassidy-Heller-Johnson bill.
Letter to House and Senate majority and minority leaders as well as the chair and ranking members of both the Senate Finance Committee and the House Energy and Commerce Committee urging reauthorizing expired healthcare programs: the Children's Health Insurance Program (CHIP), Community Health Centers (CHCs), Medicaid Disproportionate Share Hospital (DSH) payments, the Maternal and Infant Early Childhood Home Visiting Program (MIECHV), and the National Health Service Corps (NHSC).
Letter to senators and representatives urging support for S Res 336/H Res 495 Recognizing the Seriousness of Polycystic Ovary Syndrome.
Comments to Dept. of Veteran's Affairs on proposed rule that would increase access to quality health care for our nations veterans by expanding telehealth services.
Thanking Representatives for introducing the Addiction Treatment Access Improvement Act of 2017 (H.R. 3692).
Meetings with House staff on H.R.959 - Title VIII Nursing Workforce Reauthorization Act of 2017.
Meetings with House staff about maternal and infant healthcare issues.
Meetings with House staff about HR 1318 Preventing Maternal Deaths Act.
Meetings with Senate staff about S 1112 Maternal Mortality Accountability Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Seth |
Chase |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Letter to the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee opposing sections of their appropriations bill for Fiscal Year 2018 that would weaken the Food and Drug Administrations authority to oversee cigars, e-cigarettes, and certain other tobacco products.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Seth |
Chase |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Letter supporting HR 795 Employer Participation in Student Loan Assistance Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Seth |
Chase |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Letter to House and Senate leaders urging Congress to pass legislation allowing health professionals and students who are undocumented to continue their employment, education, training, and research in the United States
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Seth |
Chase |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |